JAGUAR

Jaguar Health is the majority shareholder of Napo Therapeutics S.p.A., an Italian corporation established by Jaguar Health in Milan, Italy, in 2021 that focuses on expanding crofelemer access in Europe (excluding Russia)... Jaguar Health is led by an executive management team comprised of industry-leading experts. Our Board of Directors is composed of top advisors and provides guidance and support... Jaguar Health, Inc. is a commercial-stage pharmaceutical company focused on developing novel, plant-based, nonopioid, and sustainably derived prescription medicines for people and animals with GI distress-including chronic, debilitating diarrhea.

Also known as: Jaguar Health, Jaguar Health, Inc.

Primary location: San Francisco United States